Abstract
Previously, we demonstrated that adenosine (Ado) was released by the medullary thick ascending limb (MTAL) during hypoxia. The present experiments were designed to examine the effects of Ado and adenosine analogues on net chloride (JCl) and bicarbonate (JHCO3) absorption by the isolated, perfused MTAL of the rat. Ado, 10 nM, in the presence or absence of arginine vasopressin (AVP, 10-10 M) reduced JCl by 50%. The inhibition by Ado was reproduced with the selective A1 agonist, N-6-phenylisopropyladenine (2 nM), and was reversed by 8-cyclopentyl-1,3-dipropylxanthine, an A1-receptor antagonist. Thus the inhibition of JCl is likely mediated through A1 receptors. In contrast, Ado had no effect on (JHCO3) either in the presence or absence of AVP. Ado also had no influence on the effect of AVP to inhibit JHCO3. The lack of effect on JHCO3 suggests that the inhibition of JCl by Ado is unlikely to be mediated through changes in cellular adenosine 3′,5′-cyclic monophosphate. These results support the hypothesis that Ado released into the renal medulla during hypoxia may protect the MTAL from ischemic injury by directly inhibiting NaCl absorption and reducing transport-related oxygen consumption.
Original language | English (US) |
---|---|
Pages (from-to) | F482-F487 |
Journal | American Journal of Physiology - Renal Physiology |
Volume | 263 |
Issue number | 3 |
State | Published - 1992 |
Keywords
- Adenosine 3′,5′-cyclic monophosphate
- Bicarbonate transport
- Chloride transport
- Ischemic injury
- Loop of Henle
- Renal metabolism
- Transport-related oxygen consumption
ASJC Scopus subject areas
- Urology
- Physiology